167817-55-2 | 2-Iodo-l-phenylalanine

Packsize	Purity	Availability	Price	Discounted Price
100mg	95%	in stock	$79.00	$56.00
250mg	95%	in stock	$164.00	$115.00
500mg	97%	in stock	$228.00	$160.00
1g	97%	in stock	$326.00	$228.00
5g	97%	in stock	$1,146.00	$803.00

Description

• Catalog Number: AA90014
• Chemical Name: 2-Iodo-l-phenylalanine
• CAS Number: 167817-55-2
• Molecular Formula: C9H10INO2
• Molecular Weight: 291.0857
• MDL Number: MFCD01860665
• SMILES: OC(=O)[C@H](Cc1ccccc1I)N

Computed Properties

• Complexity: 187
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 1
• Heavy Atom Count: 13
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 3
• XLogP3: -0.9

Literature

• Prospective study of p-[123I]iodo-L-phenylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions: specific confirmation of glioma.

  European journal of nuclear medicine and molecular imaging 20101201

• 99mTc-tetrofosmin SPECT for the evaluation of cerebral lesions.

  European journal of nuclear medicine and molecular imaging 20101201

• Preliminary in vivo evaluation of [131I]-2-iodo-D-phenylalanine as a potential radionuclide therapeutic agent in R1M-fluc rhabdomyosarcoma tumor-bearing NuNu mice using bioluminescent imaging.

  Cancer biotherapy & radiopharmaceuticals 20100401

• PET imaging with p-[I-124]iodo-l-phenylalanine as a new tool for diagnosis and postoperative control in patients with glioma.

  Clinical nuclear medicine 20080601

• The use of [123I]-2-iodo-L-phenylalanine as an early radiotherapy evaluation tool: in vitro R1M rabdomyosarcoma cell and in vivo mouse experiments.

  Cancer biotherapy & radiopharmaceuticals 20080401

• Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine.

  Nuclear medicine communications 20071001

• Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.

  Cancer biotherapy & radiopharmaceuticals 20060601

• Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.

  Nuclear medicine and biology 20060101

• Influence of sedation and data acquisition method on tracer uptake in animal models: [123I]-2-iodo-L-phenylalanine in pentobarbital-sedated tumor-bearing athymic mice.

  Nuclear medicine and biology 20060101

• In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20051201

• In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20050301

• Synthesis, radiosynthesis, and in vitro characterization of [125I]-2- iodo-L-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumor tracer for SPECT.

  Nuclear medicine and biology 20040801